Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37:2159–2167:

Diabetes Care ◽  
2015 ◽  
Vol 38 (7) ◽  
pp. 1393.3-1394
Author(s):  
Carol Wysham ◽  
Thomas Blevins ◽  
Richard Arakaki ◽  
Gildred Colon ◽  
Pedro Garcia ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Diabetes Care ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled

scholarly journals Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37:2149–2158

Diabetes Care ◽  
2015 ◽  
Vol 38 (3) ◽  
pp. 538-538
Author(s):  
Michael Nauck ◽  
Ruth S. Weinstock ◽  
Guillermo E. Umpierrez ◽  
Bruno Guerci ◽  
Zachary Skrivanek ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Diabetes Care ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled

scholarly journals Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial

2020 ◽  
Vol Volume 13 ◽  
pp. 423-431 ◽  
Author(s):  
Nuntakorn Thongtang ◽  
Jirasak Piyapromdee ◽  
Natthakan Tangkittikasem ◽  
Kittichai Samaithongcharoen ◽  
Nithiwat Srikanchanawat ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Primary Prevention ◽  
High Intensity ◽  
Low Dose ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled

scholarly journals Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care ◽  
2014 ◽  
Vol 37 (8) ◽  
pp. 2168-2176 ◽  
Author(s):  
Guillermo Umpierrez ◽  
Santiago Tofé Povedano ◽  
Federico Pérez Manghi ◽  
Linda Shurzinske ◽  
Valeria Pechtner
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled

scholarly journals Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211–2217

Diabetes Care ◽  
2017 ◽  
Vol 40 (9) ◽  
pp. e133-e133
Author(s):  
Miriam Méndez-del Villar ◽  
Manuel González-Ortiz ◽  
Esperanza Martínez-Abundis ◽  
Karina G. Pérez-Rubio
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Diabetes Care ◽  
Controlled Trial ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document